MAOB and Parkinson disease: For instance, ACS84 prevented neuronal death in the substantia nigra and inhibited lipid peroxidation, oxidative stress, and monoamine oxidase B (MAO-B) activity, thereby improving motor performance and surpassing the effects of NaHS and L-DOPA in Parkinson’s disease models [57].